CMMBVSNRSN• 12 Months (Normalized)
CMMB vs NRSN (Chemomab Therapeutics Ltd. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Sep 29, 2025 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-36.98%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
NRSN Performance $7.4
+%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-36.98 pts
NRSN outperforming by 36.98 percentage points
CMMBNRSN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | CMMB Price | CMMB Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -36.98% | $- | - | |
| Sep 28, 2026 | $1.64 | -38.11% | $- | - | |
| Sep 25, 2026 | $2.16 | -18.49% | $- | - | |
| Sep 24, 2026 | $2.20 | -16.98% | $- | - | |
| Sep 23, 2026 | $2.28 | -13.96% | $7.40 | +492.00% | -505.96% |
| Sep 22, 2026 | $2.51 | -5.28% | $7.18 | +474.40% | -479.68% |
| Sep 21, 2026 | $2.48 | -6.42% | $6.62 | +429.60% | -436.02% |
| Sep 18, 2026 | $2.61 | -1.51% | $6.35 | +408.00% | -409.51% |
| Sep 17, 2026 | $2.80 | +5.66% | $6.72 | +437.60% | -431.94% |
| Sep 16, 2026 | $2.65 | +0.00% | $6.49 | +419.20% | -419.20% |
| Sep 15, 2026 | $2.47 | -6.79% | $7.03 | +462.40% | -469.19% |
| Sep 14, 2026 | $2.45 | -7.55% | $6.90 | +452.00% | -459.55% |
| Sep 11, 2026 | $2.58 | -2.64% | $0.35 | -72.24% | +69.60% |
| Sep 10, 2026 | $2.60 | -1.89% | $0.33 | -73.44% | +71.55% |
| Sep 09, 2026 | $2.69 | +1.51% | $0.40 | -67.92% | +69.43% |
Page 1 of 17